Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 4/2013

01.04.2013 | Retinal Disorders

The effect of photodynamic therapy on macular sensitivity in eyes with acute central serous chorioretinopathy

verfasst von: Stefan Hagen, Siamak Ansari-Shahrezaei, Eva Smretschnig, Carl Glittenberg, Ilse Krebs, Alexandra Graf, Susanne Binder

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

To evaluate the effect of half-fluence rate indocyanine green angiography (ICGA)-guided verteporfin photodynamic therapy (PDT) on macular sensitivity (MS) in eyes with acute symptomatic central serous chorioretinopathy (CSC).

Methods

Single-center consecutive case series by retrospective chart review. Sixteen eyes of 16 patients with acute CSC of 3 months duration or less, treated with half-fluence (25 mJ/cm2) ICGA-guided verteporfin PDT were reviewed. At baseline and after 1, 3, and 6 months, all patients underwent MS testing of the central 20 °, MS testing of the retinal area covered by the PDT laser spot (MSLS), and evaluation of fixation stability (FS) for the central two degrees with the MP-1 microperimeter (Nidek, Vigonza, Italy).

Results

Macular sensitivity improved from 16.4 ± 3.0 dB at baseline (n = 16) to 18.2 ± 2.4 dB (p < 0.001) at 1 month (n = 16). At the 3-month (n = 13) and 6-month (n = 12) follow-up, MS stabilized at 19.5 ± 0.9 dB (p = 0.21) and 19.0 ± 1.3 dB (p = 0.74), without changes when compared to respective precedent follow-up. Mean MSLS improved from 12.9 ± 5.4 dB at baseline to 16.4 ± 4.9 dB (p < 0.001) after 1 month. At the 3- and 6-month follow-up, MSLS was 19.1 ± 1.2 dB (p = 0.1) and 18.9 ± 1.9 dB (p = 0.8) respectively. Mean FS at the central 2 ° was 78.8 ± 30.4 % before treatment and 81.8 ± 29.5 % (p = 0.7), 81.9 ± 27.5 % (p = 0.7) and 83.6 ± 17.1 % (p = 0.5) respectively 1, 3 and 6 months after treatment.

Conclusion

Half-fluence (25 mJ/cm2) PDT significantly increased mean MS of central 20 ° and mean MSLS, in eyes with acute symptomatic CSC. Fixation stability was stable at baseline and throughout 6 months of follow-up.
Literatur
1.
Zurück zum Zitat Guyer DR, Yannuzzi LA, Slakter JS, Sorenson JA, Ho A, Orlock D (1994) Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol 112:1057–1062PubMedCrossRef Guyer DR, Yannuzzi LA, Slakter JS, Sorenson JA, Ho A, Orlock D (1994) Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol 112:1057–1062PubMedCrossRef
2.
Zurück zum Zitat Gass JD (1967) Pathogenesis of disciform detachment of the neuroepithelium. Am J Ophthalmol 63(Suppl):1–139PubMed Gass JD (1967) Pathogenesis of disciform detachment of the neuroepithelium. Am J Ophthalmol 63(Suppl):1–139PubMed
3.
4.
Zurück zum Zitat Loo RH, Scott IU, Flynn HW Jr, Gass JD, Murray TG, Lewis ML, Rosenfeld PJ, Smiddy WE (2002) Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy. Retina 22:19–24PubMedCrossRef Loo RH, Scott IU, Flynn HW Jr, Gass JD, Murray TG, Lewis ML, Rosenfeld PJ, Smiddy WE (2002) Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy. Retina 22:19–24PubMedCrossRef
5.
Zurück zum Zitat Robertson DM (1986) Argon laser photocoagulation treatment in central serous chorioretinopathy. Ophthalmology 93:972–974PubMed Robertson DM (1986) Argon laser photocoagulation treatment in central serous chorioretinopathy. Ophthalmology 93:972–974PubMed
6.
Zurück zum Zitat Pikkel J, Beiran I, Ophir A, Miller B (2002) Acetazolamide for central serous retinopathy. Ophthalmology 109:1723–1725PubMedCrossRef Pikkel J, Beiran I, Ophir A, Miller B (2002) Acetazolamide for central serous retinopathy. Ophthalmology 109:1723–1725PubMedCrossRef
7.
Zurück zum Zitat Meyerle CB, Freund KB, Bhatnagar P, Shah V, Yannuzzi LA (2007) Ketoconazole in the treatment of chronic idiopathic central serous chorioretinopathy. Retina 27:943–946PubMedCrossRef Meyerle CB, Freund KB, Bhatnagar P, Shah V, Yannuzzi LA (2007) Ketoconazole in the treatment of chronic idiopathic central serous chorioretinopathy. Retina 27:943–946PubMedCrossRef
8.
Zurück zum Zitat Cardillo Piccolino F, Eandi CM, Ventre L, Rigault de la Longrais RC, Grignolo FM (2003) Photodynamic therapy for chronic central serous chorioretinopathy. Retina 23:752–763PubMedCrossRef Cardillo Piccolino F, Eandi CM, Ventre L, Rigault de la Longrais RC, Grignolo FM (2003) Photodynamic therapy for chronic central serous chorioretinopathy. Retina 23:752–763PubMedCrossRef
9.
Zurück zum Zitat Yannuzzi LA, Slakter JS, Gross NE, Spaide RF, Costa DL, Huang SJ, Klancnik JM Jr, Aizman A (2003) Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. Retina 23:288–298PubMedCrossRef Yannuzzi LA, Slakter JS, Gross NE, Spaide RF, Costa DL, Huang SJ, Klancnik JM Jr, Aizman A (2003) Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. Retina 23:288–298PubMedCrossRef
10.
Zurück zum Zitat Chan WM, Lam DS, Lai TY, Tam BS, Liu DT, Chan CK (2003) Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol 87:1453–1458PubMedCrossRef Chan WM, Lam DS, Lai TY, Tam BS, Liu DT, Chan CK (2003) Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol 87:1453–1458PubMedCrossRef
11.
Zurück zum Zitat Levine R, Brucker AJ, Robinson F (1989) Long-term follow-up of idiopathic central serous chorioretinopathy by fluorescein angiography. Ophthalmology 96:854–859PubMed Levine R, Brucker AJ, Robinson F (1989) Long-term follow-up of idiopathic central serous chorioretinopathy by fluorescein angiography. Ophthalmology 96:854–859PubMed
12.
Zurück zum Zitat Colucciello M (2006) Choroidal neovascularization complicating photodynamic therapy for central serous retinopathy. Retina 26:239–242PubMedCrossRef Colucciello M (2006) Choroidal neovascularization complicating photodynamic therapy for central serous retinopathy. Retina 26:239–242PubMedCrossRef
13.
Zurück zum Zitat Chan WM, Lai TY, Lai RY, Liu DT, Lam DS (2008) Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial. Ophthalmology 115:1756–1765PubMedCrossRef Chan WM, Lai TY, Lai RY, Liu DT, Lam DS (2008) Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial. Ophthalmology 115:1756–1765PubMedCrossRef
14.
Zurück zum Zitat Reibaldi M, Cardascia N, Longo A, Furino C, Avitabile T, Faro S, Sanfilippo M, Russo A, Uva MG, Munno F, Cannemi V, Zagari M, Boscia F (2010) Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy: a nonrandomized clinical trial. Am J Ophthalmol 149:307–315PubMedCrossRef Reibaldi M, Cardascia N, Longo A, Furino C, Avitabile T, Faro S, Sanfilippo M, Russo A, Uva MG, Munno F, Cannemi V, Zagari M, Boscia F (2010) Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy: a nonrandomized clinical trial. Am J Ophthalmol 149:307–315PubMedCrossRef
15.
Zurück zum Zitat Chan WM, Lai TY, Lai RY, Tang EW, Liu DT, Lam DS (2008) Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study. Retina 28:85–93PubMedCrossRef Chan WM, Lai TY, Lai RY, Tang EW, Liu DT, Lam DS (2008) Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study. Retina 28:85–93PubMedCrossRef
16.
Zurück zum Zitat Smretschnig E, Ansari-Shahrezaei S, Moussa S, Glittenberg C, Krebs I, Binder S (2012) Half-fluence photodynamic therapy in acute central serous chorioretinopathy. Retina Mar 29 [Epub ahead of print] Smretschnig E, Ansari-Shahrezaei S, Moussa S, Glittenberg C, Krebs I, Binder S (2012) Half-fluence photodynamic therapy in acute central serous chorioretinopathy. Retina Mar 29 [Epub ahead of print]
17.
Zurück zum Zitat Taban M, Boyer DS, Thomas EL, Taban M (2004) Chronic central serous chorioretinopathy: photodynamic therapy. Am J Ophthalmol 137:1073–1080PubMedCrossRef Taban M, Boyer DS, Thomas EL, Taban M (2004) Chronic central serous chorioretinopathy: photodynamic therapy. Am J Ophthalmol 137:1073–1080PubMedCrossRef
18.
Zurück zum Zitat Battaglia Parodi M, Da Pozzo S, Ravalico G (2003) Photodynamic therapy in chronic central serous chorioretinopathy. Retina 23:235–237PubMedCrossRef Battaglia Parodi M, Da Pozzo S, Ravalico G (2003) Photodynamic therapy in chronic central serous chorioretinopathy. Retina 23:235–237PubMedCrossRef
19.
Zurück zum Zitat Lai TY, Chan WM, Li H, Lai RY, Liu DT, Lam DS (2006) Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study. Br J Ophthalmol 90:869–874PubMedCrossRef Lai TY, Chan WM, Li H, Lai RY, Liu DT, Lam DS (2006) Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study. Br J Ophthalmol 90:869–874PubMedCrossRef
20.
Zurück zum Zitat Chen FK, Patel PJ, Xing W, Bunce C, Egan C, Tufail AT, Coffey PJ, Rubin GS, Da Cruz L (2009) Test-retest variability of microperimetry using the Nidek MP1 in patients with macular disease. Invest Ophthalmol Vis Sci 50:3464–3472PubMedCrossRef Chen FK, Patel PJ, Xing W, Bunce C, Egan C, Tufail AT, Coffey PJ, Rubin GS, Da Cruz L (2009) Test-retest variability of microperimetry using the Nidek MP1 in patients with macular disease. Invest Ophthalmol Vis Sci 50:3464–3472PubMedCrossRef
21.
Zurück zum Zitat Chen FK, Patel PJ, Webster AR, Coffey PJ, Tufail A, Da Cruz L (2011) Nidek MP1 is able to detect subtle decline in function in inherited and age-related atrophic macular disease with stable visual acuity. Retina 31:371–379PubMedCrossRef Chen FK, Patel PJ, Webster AR, Coffey PJ, Tufail A, Da Cruz L (2011) Nidek MP1 is able to detect subtle decline in function in inherited and age-related atrophic macular disease with stable visual acuity. Retina 31:371–379PubMedCrossRef
22.
Zurück zum Zitat Roesel M, Heimes B, Heinz C, Henschel A, Spital G, Heiligenhaus A (2011) Comparison of retinal thickness and fundus-related microperimetry with visual acuity in uveitic macular oedema. Acta Ophthalmol 89:533–537PubMedCrossRef Roesel M, Heimes B, Heinz C, Henschel A, Spital G, Heiligenhaus A (2011) Comparison of retinal thickness and fundus-related microperimetry with visual acuity in uveitic macular oedema. Acta Ophthalmol 89:533–537PubMedCrossRef
23.
Zurück zum Zitat Ehrlich R, Mawer NP, Mody CH, Brand CS, Squirrell D (2012) Visual function following photodynamic therapy for central serous chorioretinopathy: a comparison of automated macular microperimetry versus best-corrected visual acuity. Clin Experiment Ophthalmol 40:e32–e39PubMedCrossRef Ehrlich R, Mawer NP, Mody CH, Brand CS, Squirrell D (2012) Visual function following photodynamic therapy for central serous chorioretinopathy: a comparison of automated macular microperimetry versus best-corrected visual acuity. Clin Experiment Ophthalmol 40:e32–e39PubMedCrossRef
24.
Zurück zum Zitat Ansari-Shahrezaei S, Ergun E, Stur M (2006) The effect of digital measurement software on photodynamic therapy. Graefes Arch Clin Exp Ophthalmol 244:137–142PubMedCrossRef Ansari-Shahrezaei S, Ergun E, Stur M (2006) The effect of digital measurement software on photodynamic therapy. Graefes Arch Clin Exp Ophthalmol 244:137–142PubMedCrossRef
25.
Zurück zum Zitat Ansari-Shahrezaei S, Binder S, Stur M (2011) The effect of laser unit on photodynamic therapy spot size. Graefes Arch Clin Exp Ophthalmol 249:11–14PubMedCrossRef Ansari-Shahrezaei S, Binder S, Stur M (2011) The effect of laser unit on photodynamic therapy spot size. Graefes Arch Clin Exp Ophthalmol 249:11–14PubMedCrossRef
26.
Zurück zum Zitat Wu ZH, Lai RY, Yip YW, Chan WM, Lam DS, Lai TY (2011) Improvement in multifocal electroretinography after half-dose verteporfin photodynamic therapy for central serous chorioretinopathy: a randomized placebo-controlled trial. Retina 31:1378–1386PubMedCrossRef Wu ZH, Lai RY, Yip YW, Chan WM, Lam DS, Lai TY (2011) Improvement in multifocal electroretinography after half-dose verteporfin photodynamic therapy for central serous chorioretinopathy: a randomized placebo-controlled trial. Retina 31:1378–1386PubMedCrossRef
27.
Zurück zum Zitat Reibaldi M, Boscia F, Avitabile T, Uva MG, Russo A, Zagari M, Occhipinti F, Russo V, Reibaldi A, Longo A (2011) Functional retinal changes measured by microperimetry in standard-fluence vs low-fluence photodynamic therapy in chronic central serous chorioretinopathy. Am J Ophthalmol 151:953–960PubMedCrossRef Reibaldi M, Boscia F, Avitabile T, Uva MG, Russo A, Zagari M, Occhipinti F, Russo V, Reibaldi A, Longo A (2011) Functional retinal changes measured by microperimetry in standard-fluence vs low-fluence photodynamic therapy in chronic central serous chorioretinopathy. Am J Ophthalmol 151:953–960PubMedCrossRef
28.
Zurück zum Zitat Kondo M, Ito Y, Miyata K, Kondo N, Ishikawa K, Terasaki H (2006) Effect of axial length on laser spot size during photodynamic therapy: an experimental study in monkeys. Am J Ophthalmol 141:214–215PubMedCrossRef Kondo M, Ito Y, Miyata K, Kondo N, Ishikawa K, Terasaki H (2006) Effect of axial length on laser spot size during photodynamic therapy: an experimental study in monkeys. Am J Ophthalmol 141:214–215PubMedCrossRef
29.
Zurück zum Zitat Ansari-Shahrezaei S, Ergun E, Stur M (2006) The effect of axial length on photodynamic therapy. Am J Ophthalmol 141:699–702PubMedCrossRef Ansari-Shahrezaei S, Ergun E, Stur M (2006) The effect of axial length on photodynamic therapy. Am J Ophthalmol 141:699–702PubMedCrossRef
30.
Zurück zum Zitat Visudyne in Minimally Classic Choroidal Neovascularization Study Group (2005) Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration.2-year results of a randomized clinical trial. Arch Ophthalmol 123:448–457CrossRef Visudyne in Minimally Classic Choroidal Neovascularization Study Group (2005) Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration.2-year results of a randomized clinical trial. Arch Ophthalmol 123:448–457CrossRef
31.
Zurück zum Zitat Lai TY, Chan WM, Lam DS (2004) Transient reduction in retinal function revealed by multifocal electroretinogram after photodynamic therapy. Am J Ophthalmol 137:826–833PubMedCrossRef Lai TY, Chan WM, Lam DS (2004) Transient reduction in retinal function revealed by multifocal electroretinogram after photodynamic therapy. Am J Ophthalmol 137:826–833PubMedCrossRef
32.
Zurück zum Zitat Fujita K, Yuzawa M, Mori R (2011) Retinal sensitivity after photodynamic therapy with half-dose verteporfin for chronic central serous chorioretinopathy: short-term results. Retina 31:772–778PubMed Fujita K, Yuzawa M, Mori R (2011) Retinal sensitivity after photodynamic therapy with half-dose verteporfin for chronic central serous chorioretinopathy: short-term results. Retina 31:772–778PubMed
33.
Zurück zum Zitat Senturk F, Karacorlu M, Ozdemir H, Karacorlu SA, Uysal O (2011) Microperimetric changes after photodynamic therapy for central serous chorioretinopathy. Am J Ophthalmol 151:303–309PubMedCrossRef Senturk F, Karacorlu M, Ozdemir H, Karacorlu SA, Uysal O (2011) Microperimetric changes after photodynamic therapy for central serous chorioretinopathy. Am J Ophthalmol 151:303–309PubMedCrossRef
34.
Zurück zum Zitat Ozdemir H, Senturk F, Karacorlu M, Arf Karacorlu S, Uysal O (2008) Macular sensitivity in eyes with central serous chorioretinopathy. Eur J Ophthalmol 18:799–804PubMed Ozdemir H, Senturk F, Karacorlu M, Arf Karacorlu S, Uysal O (2008) Macular sensitivity in eyes with central serous chorioretinopathy. Eur J Ophthalmol 18:799–804PubMed
Metadaten
Titel
The effect of photodynamic therapy on macular sensitivity in eyes with acute central serous chorioretinopathy
verfasst von
Stefan Hagen
Siamak Ansari-Shahrezaei
Eva Smretschnig
Carl Glittenberg
Ilse Krebs
Alexandra Graf
Susanne Binder
Publikationsdatum
01.04.2013
Verlag
Springer-Verlag
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 4/2013
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-012-2139-9

Weitere Artikel der Ausgabe 4/2013

Graefe's Archive for Clinical and Experimental Ophthalmology 4/2013 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.